WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

KR

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

KR

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

KR

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

KR

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

KR

66.66

-1.02%↓

Search

Afya Ltd (Class A)

Открыт

СекторПотребительские товары
(защитный сектор)

14 0.14

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

13.71

Макс.

14.11

Ключевые показатели

By Trading Economics

Доход

-5M

176M

Продажи

-1.6M

927M

P/E

Средняя по отрасли

9.588

29.378

Дивидендная доходность

4.14

Рентабельность продаж

18.945

Сотрудники

9,395

EBITDA

-120M

277M

Рекомендации

By TipRanks

Рекомендации

Продажа

Прогноз на 12 месяцев

+18.11% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

4.14%

4.42%

Следующий отчет о доходах

7 мая 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

149M

1.4B

Предыдущая цена открытия

13.86

Предыдущая цена закрытия

14

Новостные настроения

By Acuity

100%

0%

125 / 131 Рейтинг в Consumer defensive

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Afya Ltd (Class A) График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

26 апр. 2026 г., 21:14 UTC

Главные новостные события

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26 апр. 2026 г., 21:14 UTC

Главные новостные события

Week Ahead for FX, Bonds: Major Central Bank -2-

24 апр. 2026 г., 19:19 UTC

Приобретения, слияния, поглощения

Intertek Group Rejects EQT's Revised Offer

26 апр. 2026 г., 23:48 UTC

Обсуждения рынка

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26 апр. 2026 г., 23:44 UTC

Отчет

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26 апр. 2026 г., 23:44 UTC

Отчет

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26 апр. 2026 г., 23:36 UTC

Обсуждения рынка
Главные новостные события

Gold Falls Amid Dollar's Strength -- Market Talk

26 апр. 2026 г., 23:33 UTC

Обсуждения рынка
Главные новостные события

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26 апр. 2026 г., 05:12 UTC

Отчет

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26 апр. 2026 г., 05:12 UTC

Отчет

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26 апр. 2026 г., 05:12 UTC

Отчет

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26 апр. 2026 г., 05:12 UTC

Отчет

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24 апр. 2026 г., 23:37 UTC

Приобретения, слияния, поглощения

Scoring the Cook Era -- Barrons.com

24 апр. 2026 г., 20:51 UTC

Приобретения, слияния, поглощения

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 апр. 2026 г., 20:50 UTC

Обсуждения рынка
Главные новостные события

Financial Services Roundup: Market Talk

24 апр. 2026 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

24 апр. 2026 г., 20:39 UTC

Приобретения, слияния, поглощения

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 апр. 2026 г., 20:09 UTC

Отчет

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 апр. 2026 г., 19:48 UTC

Обсуждения рынка
Главные новостные события

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 апр. 2026 г., 19:25 UTC

Приобретения, слияния, поглощения

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 апр. 2026 г., 19:25 UTC

Приобретения, слияния, поглощения

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 апр. 2026 г., 19:22 UTC

Отчет

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 апр. 2026 г., 19:06 UTC

Отчет

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 апр. 2026 г., 19:05 UTC

Обсуждения рынка

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 апр. 2026 г., 18:30 UTC

Приобретения, слияния, поглощения

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 апр. 2026 г., 18:28 UTC

Приобретения, слияния, поглощения

Intertek Rejects Revised EQT Offer

24 апр. 2026 г., 18:12 UTC

Обсуждения рынка

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 апр. 2026 г., 18:06 UTC

Обсуждения рынка

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 апр. 2026 г., 17:42 UTC

Отчет

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 апр. 2026 г., 17:28 UTC

Отчет

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Сравнение c конкурентами

Изменение цены

Afya Ltd (Class A) Прогноз

Целевая цена

By TipRanks

18.11% рост

Прогноз на 12 месяцев

Средняя 16.5 USD  18.11%

Максимум 17 USD

Минимум 16 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Afya Ltd (Class A) на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Продажа

2 ratings

0

Покупка

1

Удержание

1

Продажа

Техническая оценка

By Trading Central

18.968 / 19.56Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Strong Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
help-icon Live chat